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Abstract
 
Little is known of age-associated functional changes in hematopoietic stem cells (HSCs). We
 
studied aging HSCs at the clonal level by isolating CD34
 
2
 
/low
 
c-Kit
 
1
 
Sca-1
 
1
 
 lineage marker–
negative (CD34
 
2
 
KSL) cells from the bone marrow of C57BL/6 mice. A population of
CD34
 
2
 
KSL cells gradually expanded as age increased. Regardless of age, these cells formed in
vitro colonies with stem cell factor and interleukin (IL)-3 but not with IL-3 alone. They did
not form day 12 colony-forming unit (CFU)-S, indicating that they are primitive cells with
myeloid differentiation potential. An in vivo limiting dilution assay revealed that numbers of
multilineage repopulating cells increased twofold from 2 to 18 mo of age within a population
of CD34
 
2
 
KSL cells as well as among unseparated bone marrow cells. In addition, we detected
another compartment of repopulating cells, which differed from HSCs, among CD34
 
2
 
KSL
cells of 18-mo-old mice. These repopulating cells showed less differentiation potential toward
lymphoid cells but retained self-renewal potential, as suggested by secondary transplantation.
We propose that HSCs gradually accumulate with age, accompanied by cells with less lym-
phoid differentiation potential, as a result of repeated self-renewal of HSCs.
Key words: mouse • bone marrow transplantation • hematopoiesis • self-renewal • 
differentiation
 
Introduction
 
Aging of individuals is defined by two criteria: increasing
probability of death with age and characteristic changes in
phenotype over time (1). As hematopoietic stem cells
(HSCs)
 
1
 
 are able to self-renew and to differentiate along all
hematopoietic lineages throughout the entire lifetime of an
organism (2), it has been questioned whether HSCs age.
Evaluation of HSC life-span has been challenged by serial
transplantation. Aged bone marrow cells were able to re-
constitute hematopoiesis of the recipients after multiple
transfers as wells as young bone marrow cells (3–5). This
observation was supported by a recent study showing that
HSCs from young and old mice exhibited indistinguishable
repopulating abilities at the clonal level (6). It has been sug-
gested that transplantation, as a procedure, adversely affects
the repopulating activity of HSCs (5, 7). Nonetheless, it is
evident that HSCs can function far longer than the life-
span of their donor even if their capacity for self-renewal is
limited (8, 9).
Competitive repopulation has revealed another age-asso-
ciated feature of hematopoiesis. The repopulating activity
of bone marrow cells from aged mice is higher than that of
cells from young mice (10). This might be caused by quali-
tative and/or quantitative changes in aged HSCs as com-
pared with young HSCs. Analyses using the binomial for-
mula with covariance suggested that the frequency of
HSCs was relatively higher in aged bone marrow cells (11).
However, the mechanism by which repopulating activity
rises in aged bone marrow cells remains elusive. These
findings collectively argue against defective hematopoiesis
in aged mice.
 
Our study focused on the characterization of age-associ-
ated functional changes in HSCs in mice. A twofold in-
crease in numbers of multilineage repopulating cells from 2
to 18 mo of age was demonstrated by limiting dilution anal-
ysis with unseparated bone marrow cells. We noticed the
existence of recipients in which only myeloid lineage was
reconstituted at significant level among irradiated mice
transplanted with a limited dose of bone marrow cells from
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aged mice, but not from young mice. To extend these ob-
servations, we analyzed repopulating cells at the clonal level.
We have shown that CD34
 
2
 
/low
 
c-Kit
 
1
 
Sca-1
 
1 
 
lineage
marker–negative (CD34
 
2
 
KSL) bone marrow cells are
highly enriched for HSCs (12). A population of these cells
appeared to expand with age. It was shown that multilin-
eage repopulating cell number also increased twofold
among CD34
 
2
 
KSL cells from 2 to 18 mo of age. We
thereupon found another compartment of repopulating
cells, whose differentiation potential was skewed toward
myeloid lineage, among aged CD34
 
2
 
KSL cells. Successful
secondary transplantation indicated that self-renewal po-
tential was maintained in these unusual repopulating cells.
Cell cycle kinetics was taken into consideration in deter-
mining that CD34
 
2
 
KSL cell numbers expanded. We
present an age-associated effect on hematopoiesis at the
HSC level.
 
Materials and Methods
 
Mice and Cells.
 
C57BL/6 male (B6-Ly5.2) mice were pur-
chased from Charles River Japan, Inc. Aged C57BL/6 mice were
provided by Dr. K. Hirokawa (Tokyo Medical and Dental Uni-
versity, Tokyo, Japan). Mice congenic for the Ly5 locus (B6-
Ly5.1) were bred and maintained in the University of Tsukuba
Animal Research Center. The Animal Experiment Committee of
the University of Tsukuba approved animal use and care. B6-
Ly5.1/Ly5.2 (B6-F1) mice were obtained from mating pairs of
B6-Ly5.1 and B6-Ly5.2 mice. Bone marrow cells were obtained
from both right and left femora and tibiae of B6-Ly5.1 and B6-F1
male mice. Test donor cells were prepared from B6-Ly5.1 mice
at 2, 6, 12, and 18 mo of age. Competitor cells were prepared
from B6-F1 mice at 2 mo of age. Recipients were B6-Ly5.2 male
mice aged 2 mo.
 
Analysis and Purification of CD34
 
2
 
KSL Cells.
 
CD34
 
2
 
KSL
cells were purified from bone marrow cells as previously de-
scribed (12). In brief, cells with low density (
 
,
 
1.077 g/ml) were
stained with an appropriate amount of biotinylated lineage–anti-
body mixture consisting of anti–Gr-1 (RB6-8C5), Mac-1 (M1/
70), B220 (RA3-6B2), CD4 (GK1.5), CD8 (53-6.7), and Ter-
119 mAbs. Lineage-positive cells were depleted with streptavi-
din–magnetic beads (M-280; Dynal). The cells were further
stained with PE-conjugated anti–Sca-1, allophycocyanin (APC)-
conjugated anti–c-Kit (ACK-2), and fluorescein isothiocyanate
(FITC)-conjugated anti-CD34 (49E8) antibodies. Biotinylated
antibodies were developed with streptavidin–Texas Red (Life
Technologies). All antibodies other than ACK-2 (a gift of Dr.
S.I. Nishikawa, Kyoto University, Kyoto, Japan) were purchased
from PharMingen. Four-color analysis was performed on a FACS
Vantage™ (Becton Dickinson) using CELLQuest™ software
(Becton Dickinson). CD34
 
2
 
KSL cells were sorted with the
counter mode. Dead cells stained with propidium iodide (PI)
were excluded from analysis and sorting.
 
Competitive Repopulation Assay.
 
The Ly5 system was adapted
to a competitive repopulation assay (13) as described (14). Un-
fractionated or purified bone marrow cells to be tested were
mixed with 2 
 
3 
 
10
 
5
 
 bone marrow cells as competitor cells and
were transplanted into B6-Ly5.2 mice irradiated at a dose of 9.5
Gy. In vivo limiting dilution was performed as described (15).
Three or more different numbers of test donor cells were sub-
jected to competitive repopulation against 2 
 
3 
 
10
 
5
 
 bone marrow
 
cells. At indicated time points after transplantation, peripheral
blood cells of the recipients were obtained by retroorbital bleed-
ing and were stained with biotinylated anti-Ly5.1 (A20) and
FITC-conjugated anti-Ly5.2 antibodies (104). The cells were si-
multaneously stained with APC-conjugated anti-B220 antibody
together with a mixture of PE-conjugated anti–Mac-1 and –Gr-1
antibodies or PE-conjugated anti-CD4 and -CD8 antibodies.
The cells were stained last with streptavidin–Texas Red. Four-
color analysis was performed on a FACS
 
®
 
. The percent chimer-
ism was calculated, based on FACS
 
® 
 
analyses, as follows: (percent
test donor–derived cells) 
 
3 
 
100/(percent test donor–derived
cells 
 
1 
 
percent competitor-derived cells). In this study, test donor
cells were prepared from B6-Ly5.1 mice, and competitor cells
were prepared from B6-F1 mice. Thus, percent chimerism 
 
5
 
(percent Ly5.1 cells) 
 
3 
 
100/(percent Ly5.1 cells 
 
1 
 
percent F1
cells). The percent chimerism for myeloid and B or T lymphoid
cells was calculated using the same formula. For example, the
percent chimerism for B lymphoid cells 
 
5 
 
(percent B220
 
1
 
 
 
Ly5.1
cells) 
 
3
 
 100/(percent B220
 
1
 
 
 
Ly5.1 
 
1 
 
percent B220
 
1
 
 F1 cells).
When the percent chimerism was 
 
.
 
1.0 in all lineages (myeloid
and B and T lymphoid lineages), recipient mice were considered
to be multilineage reconstituted.
 
Secondary Transplantation.
 
Bone marrow cells from primary
recipient mice were transferred into lethally irradiated B6-Ly5.2
mice (2 
 
3 
 
10
 
6
 
 cells per recipient). Competition between test and
competitor donor cells in secondary recipients was evaluated as in
primary recipients.
 
In Vivo and In Vitro Colony Assays.
 
CFU-S assay was per-
formed as described (16). Purified cells were injected into lethally
irradiated mice. Spleens were removed from the recipients at day
12 after transplantation. After fixation with Bouin solution, num-
bers of spleen colonies were counted. For in vitro colony assays,
individual cells were directly sorted into a round-bottomed 96-
well plate containing 10% FCS, 5 
 
3 
 
10
 
2
 
4
 
 2-
 
b
 
-mercaptoethanol,
10 ng/ml mouse (m)IL-3, and 10 ng/ml mouse stem cell factor
(mSCF) in 
 
a
 
-medium. Both mIL-3 and mSCF were provided by
Kirin Brewery Co., Takasaki, Japan. Colony formation was ob-
served on day 14 of culture.
 
Analysis of Cell Cycle.
 
Sorted cells were fixed with 70% etha-
nol in water at 4
 
8
 
C for one night. The cells were stained with 30
 
m
 
g/ml PI in staining medium containing 11.25 Kunitz units of
RNase A at 37
 
8
 
C for 30 min. Cell cycle analyses were performed
on a FACSCalibur™ (Becton Dickinson). Collected data were
analyzed by ModFit LT (version 2.0; Verity Software House,
Inc.).
To investigate the turnover rate of CD34
 
2
 
KSL cells, bro-
modeoxyuridine (BrdU; Sigma-Aldrich) was administered con-
tinuously to mice via drinking water. A bottle of water containing
0.5 mg/ml BrdU was changed weekly. After BrdU incorporation
in vivo, CD34
 
2
 
KSL cells were isolated and stained with FITC-
conjugated anti-BrdU (Becton Dickinson) and PI as previously
described (17). The cells were analyzed on a FACS Vantage™.
 
Results
 
Repopulating Activity in Bone Marrow Cells of Aging
Mice.
 
We compared repopulating activity of unseparated
bone marrow cells from B6 mice of different ages. Table I
shows the result of reconstitution analyses 24 wk after
transplantation. The percentages of chimerism obtained af-
ter transplantation by bone marrow cells from mice aged 6,
12, and 18 mo were higher than those obtained by bone 
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marrow cells from mice aged 2 mo. These data are consis-
tent with previous observations (6, 10). We noticed that
the degree of myeloid reconstitution was significantly
higher than that of B lymphoid reconstitution when bone
marrow cells from mice aged 18 mo were transplanted.
 
Absolute Numbers of Multilineage Repopulating Cells.
 
To
compare numbers of repopulating cells in mouse bone
marrow cells at 2 and 18 mo of age, we performed in vivo
limiting dilutions with unseparated bone marrow cells from
mice of each age. At 12 wk after transplantation, peripheral
blood cells were analyzed for the presence of test donor
cell–derived cells for each lineage. Reconstitution in all
myeloid and B and T lymphoid lineages was obligatory for
multilineage repopulating cells.
 
The percentages of negative mice in a logarithmic func-
tion were plotted against the number of cells transplanted
(Fig. 1). According to the Poisson distribution, the fre-
quency of competitive repopulating units (15) was esti-
mated using the maximum likelihood (18, 19). 1 in 1.6 
 
3
 
10
 
4
 
 bone marrow cells was a multilineage repopulating cell
in aging mice, whereas in young mice, 1 in 3.2 
 
3 
 
10
 
4
 
 cells
was such as a cell. As there was no significant difference in
total numbers of nucleated bone marrow cells between 2
and 18 mo of age (Table II), it was concluded that the
number of HSCs increased twofold from 2 to 18 mo of age.
We observed recipient mice in which the myeloid lineage
appeared to be reconstituted, without significant repopula-
tion of B and/or T lymphoid cells, when 1.5 
 
3 
 
10
 
4
 
 or fewer
test donor cells from 18-mo-old mice were transplanted.
When these reconstituted mice were taken into account,
the frequency of repopulating cells was 1 in 1.0 
 
3 
 
10
 
4
 
 bone
marrow cells. Thus, by calculation, at 18 mo of age, there
were 6.3 multilineage repopulating cells, and 3.7 repopulat-
ing cells that were less capable of giving rise to lymphoid
cells, per 10
 
5
 
 bone marrow cells. As we did not detect the
latter type of repopulating cells in 2-mo-old mice, we pos-
tulated that unusual repopulating cells were present in aging
mice in addition to multilineage repopulating cells.
 
CD34
 
2
 
KSL Cells in the Bone Marrow.
 
We have
shown that HSCs are highly enriched in a population of
CD34
 
2
 
KSL bone marrow cells. Consistent with the previ-
ous data (12), CD34
 
2
 
KSL cells accounted for 0.005% of
bone marrow cells at 2 mo of age. The percentage of these
cells increased about 2-, 4-, and 17-fold on average by 6,
12, and 18 mo of age, respectively, as shown in Table II. As
the total number of bone marrow cells remained constant
from 2 to 18 mo of age, the absolute number of
CD34
 
2
 
KSL cells increased proportionally with age.
 
In Vivo and In Vitro Colony-forming Ability of Aged
CD34
 
2
 
KSL Cells.
 
To clarify whether CD34
 
2
 
KSL cells
that increased in number with age were functionally simi-
lar to those of young mice, colony-forming abilities of
 
Table I.
 
Repopulating Activities of Bone Marrow Cells from Mice of Different Ages
 
Percent chimerism
Age of mice Total Myeloid B lymphoid T lymphoid
 
mo
 
2 30.9 
 
6
 
 31.9 (
 
n
 
 
 
5
 
 11) 28.8 
 
6
 
 35.6 (
 
n
 
 
 
5
 
 11) 30.9 
 
6
 
 28.9 (
 
n
 
 
 
5
 
 11) 34.3 
 
6
 
 31.7 (
 
n
 
 
 
5
 
 11)
6 62.0 
 
6
 
 17.9
 
*
 
 (
 
n
 
 
 
5
 
 7) 65.9 
 
6
 
 24.4 (
 
n
 
 
 
5
 
 7) 57.6 
 
6
 
 16.1 (
 
n
 
 
 
5
 
 7) 63.6 
 
6
 
 22.5 (
 
n
 
 
 
5
 
 7)
12 49.4 
 
6
 
 28.6 (
 
n
 
 
 
5
 
 8) 55.5 
 
6
 
 35.2 (
 
n
 
 
 
5
 
 8) 43.3 
 
6
 
 24.6 (
 
n
 
 
 
5
 
 8) 47.9 
 
6
 
 30.0 (
 
n
 
 
 
5 8)
18 60.1 6 19.7* (n 5 11) 72.3 6 35.2‡ (n 5 11) 52.5 6 20.6 (n 5 11) 55.5 6 26.4 (n 5 11)
2 3 105 bone marrow cells from 2-, 6-, 12-, or 18-mo-old B6-Ly5.1 mice were mixed with 2 3 105 bone marrow cells from 2-mo-old B6-F1 mice
and transplanted into lethally irradiated B6-Ly5.2 mice. 24 wk after transplantation, peripheral blood cells were analyzed for the percent chimerism
for total leukocytes and for myeloid and B and T lymphoid cells. The data are expressed as the mean 6 SD. The numbers of recipients are shown in
parentheses.
*Percent chimerism at 6 and 18 mo of age significantly higher than that at 2 mo of age (P , 0.05, Mann-Whitney U test). 
‡Percent chimerism in myeloid lineage significantly higher than that in B lymphoid lineage (P , 0.05, Student’s t test).
Figure 1. Limiting dilution analysis based on competitive repopulation.
Varying numbers of bone marrow cells from either 2- or 18-mo-old mice
were mixed with 2 3 105 bone marrow cells from 2-mo-old mice and in-
jected into lethally irradiated mice. Reconstitution in myeloid and B and
T lymphoid lineages was evaluated 12 wk after transplantation. Mice
were considered to be negative when percent chimerism for myeloid or B
or T lymphoid lineage was ,1.0. 1 in 3.2 3 104 cells and 1 in 1.6 3 104
cells was a multilineage repopulating cell for 2-mo-old (j) and 18-mo-
old (d) mice. When uni- and bilineage repopulating cells were included
in estimations of frequencies, 1 in 1.0 3 104 cells was a repopulating cell
in 18-mo-old mice (s).1276 Age-associated Characteristics of Murine Hematopoietic Stem Cells
CD342KSL cells at different ages were compared (Table
III). Regardless of age, most CD342KSL cells did not give
rise to day 12 spleen colonies (CFU-Sd12), nor did these
cells form in vitro colonies in the presence of IL-3 alone.
However, a large proportion (70–80%) of the CD342KSL
cells formed colonies in the presence of SCF and IL-3, ir-
respective of age. These data indicate that expanded CD342
KSL cells in aging mice have myeloid differentiation po-
tential similar to that of such cells in young mice.
Long-Term Reconstitution with Limited Numbers of CD342
KSL Cells from Old Mice. We evaluated the in vivo func-
tion of CD342KSL cells from 18-mo-old mice and deter-
mined the frequency of multilineage repopulating cells
among these cells by limiting dilution analysis. Graded
numbers of CD342KSL cells were transplanted into irradi-
ated mice. The recipient mice were analyzed at 16 wk after
transplantation. As shown in Fig. 2, multilineage repopulat-
ing cells were detected at a frequency of 1 in 23 cells. Mul-
tilineage reconstitution was detected in a recipient mouse,
as demonstrated in Fig. 3 A. Both CD342KSL cells at 18
mo of age and competitor cells at 2 mo of age contributed
to reconstitution in myeloid and B and T lymphoid lin-
eages. Based on the percentage of CD342KSL cells among
bone marrow cells (Table II) and the estimated frequency
of multilineage repopulating cells among CD342KSL cells
(Fig. 2), it was calculated that at 18 mo of age, 3.8 cells per
105 bone marrow cells were multilineage repopulating with
the CD342KSL phenotype. This frequency was nearly
twice that in young mice (12).
Of note is that among mice transplanted with 10
CD342KSL cells, a dose less than the threshold number for
the presence of a multilineage repopulating cell, we again
observed mice in which reconstitution was detected only
for myeloid lineage, as demonstrated in Fig. 3 B. In four
out of nine cases, total chimerism and myeloid chimerism
were both .1%, but B and T lymphoid chimerism was
,1% (Table IV). We designated the repopulating cells with
undetectable lymphoid differentiation potential as defective
repopulating cells. The percentages of chimerism for total
leukocytes were relatively low in the cases reconstituted
with defective repopulating cells, reflecting low chimerism
in lymphoid lineage. It was estimated that multilineage and
defective repopulating cells were present, taken together, at
Table II. Bone Marrow Cellularity and Populations of CD342KSL Cells at Different Ages
Age of mice No. mice analyzed No. bone marrow cells Lin2 cells CD342KSL cells 
mo 3107/hindlimbs % %
2 8 6.4 6 1.2 1.57 6 0.23 0.005 6 0.002
6 6 6.5 6 0.6 1.49 6 1.20 0.011 6 0.005
12 8 5.4 6 0.9 1.58 6 0.25 0.042 6 0.015
18 6 6.4 6 0.5 2.03 6 0.30 0.087 6 0.039
Bone marrow cells were collected from both right and left femora and tibiae. The number of bone marrow cells is presented as the mean 6 SD per
mouse. Percent lineage marker–negative (Lin2) cells and percent CD342KSL cells in bone marrow cells is shown.
Table III. In Vivo and In Vitro Colony Formation by 
CD342KSL Cells of Different Ages
Percent colony-forming cells
Age of mice CFU-Sd12 CFU-CIL-3 CFU-CIL-31SCF
mo
2 0.8 6 0.7 0.3 6 0.5 79.8 6 5.5
6 1.2 6 0.7 2.1 6 0.5 70.5 6 8.5
12 0.7 6 0.2 1.3 6 0.9 76.7 6 3.9
18 1.1 6 0.2 1.5 6 1.0 76.7 6 3.9
The frequency of colony-forming cells among CD342KSL cells is
presented as the mean 6 SD (n  5 4). 200 CD342KSL cells were
injected into irradiated mice for day 12 CFU (CFU-Sd12) assay. A single
cell culture of CD342KSL cells was performed in the presence of IL-3
alone (CFU-CIL-3) or of IL-3 plus SCF (CFU-CIL-31SCF). In vitro
colony formation was evaluated on day 14 of culture.
Figure 2. Limiting dilution analysis on CD342KSL cells from 18-mo-
old mice. Graded numbers of CD342KSL cells were mixed with 2 3 105
bone marrow competitor cells and transplanted into irradiated mice. Pe-
ripheral blood cells of the recipients were analyzed for the presence of
CD342KSL-derived cells 16 wk after transplantation. The frequencies of
multilineage repopulating cells (d) and a total of multilineage repopulat-
ing cells and myeloid-dominant repopulating cells (s) were estimated as
1 in 23 and 1 in 13 CD342KSL cells, respectively.1277 Sudo et al.
a frequency of 1 per 13 CD342KSL cells (Fig. 2). Thus, the
total of both types of repopulating cells was calculated to be
6.7 cells per 105 bone marrow cells. As the frequency of
multilineage repopulating cells was estimated to be 3.8 cells
per 105 bone marrow cells, defective repopulating cells
were inferred to be present at a frequency of 2.9 cells per
105 bone marrow cells from 18-mo-old mice. An accumu-
lation of defective repopulating cells might contribute to
high myeloid reconstitution, with low lymphoid reconsti-
tution, after transplantation with aging bone marrow cells.
Expansion in numbers of these two types of repopulating
cells accounted for high repopulating activity of aging bone
marrow cells.
In addition, we concluded that most CD342KSL cells in
aging mice were myeloid lineage–committed precursor
cells. Over 70 percent of these cells formed colonies on
stimulation by SCF and IL-3 but lacked CFU-S activity.
Most cells did not show repopulating activity. We inferred
that such cells lie in the developmental stages between re-
populating cells and CFU-S.
Secondary Transplantation of Bone Marrow Cells Repopulated
with 10 CD342KSL Cells. We addressed whether or not
defective repopulating cells still have self-renewal potential.
One case with multilineage reconstitution and two cases
with myeloid dominant reconstitution (Table IV; mice
Nos. 1, 2, and 3) were subjected to secondary transplanta-
tion. Bone marrow cells of the primary recipients were
transferred into irradiated mice 16 wk after primary trans-
plantation. The secondary recipient mice were analyzed
between 12 and 16 wk after transplantation.
Table V summarizes the percentages of chimerism in the
secondary recipients. With mouse No. 1, high levels of re-
constitution occurred in myeloid and B and T lymphoid
lineages in all secondary recipients. Multilineage repopulat-
ing cells appeared to be forced to self-renew in secondary
recipients.
On the other hand, with mouse No. 2, the recipients
showed wide variations in reconstitution. Reconstitution
levels in individual recipients are shown in Table V. Re-
constitution in myeloid and both B and T lymphoid lin-
eages occurred in 6 out of 10 recipients. Myeloid and T
lymphoid, but not B lymphoid, cells were reconstituted in
3 cases. In one recipient, only myeloid reconstitution was
significant. On average, lymphoid lineage chimerism re-
mained significantly lower than myeloid lineage. With
mouse No. 3, 3 out of 9 recipients were not reconstituted
with CD342KSL-derived cells. Reconstitution was detect-
able only in myeloid lineage for the rest. It should be em-
phasized that predominance of myeloid lineage reconstitu-
tion persisted in secondary recipients with both mice Nos.
2 and 3 and that defective repopulating cells exhibited par-
ticularly profound reductions in generation of B cells.
Figure 3. FACS® profiles for re-
constitution analysis. Data are from
recipients transplanted with a limited
number of CD342KSL cells from
18-mo-old mice. At 16 wk after
transplantation, peripheral blood
cells were analyzed for contributions
of test donor cells, which were dis-
tinguished as Ly5.1 cells. Multilin-
eage reconstitution was detected
in a mouse transplanted with 20
CD342KSL cells, as shown in A.
Myeloid lineage was predominately
reconstituted in a mouse trans-
planted with 10 CD342KSL cells
(Table IV, mouse No. 2), as shown
in B. Note good repopulation in all
lineages by F1 competitor cells in
both cases.
Table IV. Transplantation of 10 CD342KSL Bone Marrow 
Cells from 18-mo-old Mice
Percent chimerism
Mouse no. Total Myeloid B lymphoid T lymphoid
1* 49.4 93.7 1.5 3.7
2* 11.7 47.9 0.1 0.2
3* 7.3 15.7 0.7 0.2
4 2.1 7.5 0.3 0.2
5 1.1 2.8 0.8 0.1
6 0.8 3.2 0.0 0.3
7 0.4 0.3 0.2 0.1
8 0.2 0.1 0.2 0.7
9 0.1 0.2 0.1 0.0
Irradiated B6-Ly5.2 mice were injected with a mixture of 10
CD342KSL cells from 18-mo-old B6-Ly5.1 mice and 2 3 105 bone
marrow cells from 2-mo-old B6-F1 mice. Peripheral blood cells of the
recipients were evaluated for engraftment 16 wk after transplantation.
Percent chimerism is shown for all Ly5.1 leukocytes and Ly5.1 cells in
myeloid and B and T lymphoid cells.
*Mice serving as donors for secondary transplantation.1278 Age-associated Characteristics of Murine Hematopoietic Stem Cells
These data indicate the existence of repopulating cells
whose differentiation potential along lymphoid lineage is
reduced but whose self-renewal potential is maintained.
Significant levels of lymphoid lineage reconstitution ap-
peared in some of the mice transplanted with defective re-
populating cells (mouse No. 2). This indicates that the per-
centage of chimerism in primary recipients shows only
relative repopulating activity but not the presence or ab-
sence of repopulating activity in test donor cells. We con-
cluded that the differentiation potential of defective HSCs
was amplified into detectability when these cells were
forced to self-renew by secondary transplantation.
Cell Cycle Analysis of CD342KSL Cells. We analyzed
the cell cycle status of an expanded population of
CD342KSL cells. CD342KSL cells isolated from mice of
different ages were stained with PI and analyzed on a
FACS®. As summarized in Table VI, 2.2, 0.8, 1.5, and
1.8% of the CD342KSL cells were in S/G2/M phases of
the cell cycle at 2, 6, 12, and 18 mo of age, respectively.
Thus, at any one time, the cell cycle status of these cells was
steady from 2 to 18 mo of age.
To study the turnover rate of a population of CD342KSL
cells, mice aged 2 mo were fed water containing BrdU over
varying periods of time. CD342KSL cells were then iso-
lated, and BrdU incorporation by these cells was analyzed.
As shown in Fig. 4, z50% of CD342KSL cells were labeled
with BrdU by day 7 of administration, whereas .80% of the
lineage marker–negative cells were labeled with BrdU.
However, both cell populations gradually came to be la-
beled with BrdU after 2 wk of administration. From the
transformed data as presented in Fig. 4 B, it was estimated
that the average turnover time and 50% turnover time of
CD342KSL cells was 30 and 21 d, respectively. These esti-
mations were consistent with data obtained using rhodamine
123 low, Hoechst 33342 low cells, which have been shown
to represent HSCs in the murine bone marrow (17).
Discussion
We have demonstrated age-associated features of HSCs
in B6 mice: (a) an expansion of the HSC pool and (b) an
Table V. Secondary Transplantation of Defective Repopulating Cells
Percent chimerism*
Primary recipient Total Myeloid B lymphoid T lymphoid
No. 1 88.8 6 10.8 (n 5 5) 77.5 6 18.8 (n 5 5) 94.9 6 8.4 (n 5 5) 90.0 6 9.0 (n 5 5)
No. 2 51.0 6 25.8 (n 5 10) 73.4 6 34.6 (n 5 10) 4.0 6 5.5 (n 5 10) 21.0 6 21.3 (n 5 10)
80.7 97.4 11.9 55.8
68.0 91.9 14.3 10.9
58.3 80.0 1.6 2.0
55.9 71.6 1.4 61.3
50.7 93.7 8.7 20.6
12.3 12.2 1.2 19.6
78.8 93.0 0.4 22.3
53.3 98.2 0.4 3.4
50.5 89.0 0.1 13.4
1.5 7.2 0.0 0.2
No. 3 9.2 6 7.9 (n 5 6) 26.2 6 15.5 (n 5 6) 0.1 6 0.1 (n 5 6) 0.3 6 0.2 (n 5 6)
The primary recipients listed as mice Nos. 1, 2, and 3 in Table IV served as donors for secondary transplantation. Lethally irradiated mice were
transplanted with 2 3 106 bone marrow cells per mouse 16 wk after primary transplantation. Between 12 and 16 wk after secondary transplantation,
the recipients were analyzed for percent chimerism of CD342KSL-derived cells.
*Mean 6 SD.
Table VI. Cell Cycle Status of CD342KSL Cells
Age of mice (mo)
Cell cycle phase 2 6 12 18
G0/G1 97.8% 99.2% 98.5% 98.2%
G2/M 0.1% 0.4% 1.0% 0.7%
S 2.1% 0.4% 0.5% 1.1%
CD342KSL cells were sorted from bone marrow cells of 2-, 6-, 12-, or
18-mo-old mice and stained with PI. Approximately 5,000 cells were
analyzed on a FACS® using ModFit software.1279 Sudo et al.
accumulation of defective HSCs and myeloid lineage–
committed progenitors. Defective HSCs were defined as
repopulating cells capable of both self-renewal and differ-
entiation into myeloid cells but incapable of balanced gen-
eration of lymphoid cells.
Table VII summarizes the kinetics of CD342KSL cells.
The absolute number of CD342KSL cells increased z17-
fold from 2 to 18 mo of age. Features of these cells at both
ages were calculated based on the data presented above.
The frequencies of HSCs and defective HSCs with
CD342KSL phenotype at 2 mo of age, which have been
recently estimated using a single cell transplantation assay
(Sudo, K., H. Ema, Y. Morita, and H. Nakauchi, manu-
script in preparation), are also included in Table VII. Ap-
proximately 20% of the CD342KSL cells at 2 and 18 mo
of age did not show any activity in colony assays and in
competitive repopulation. These cells are listed as uniden-
tified cells.
Numbers of HSCs increased about twofold among
CD342KSL cells. When unseparated bone marrow cells
were examined, it was estimated that HSCs were present at
rates of 3.2 and 6.3 cells in 105 bone marrow cells at 2 and
18 mo of age, respectively (Fig. 1). Thus, a twofold in-
crease of HSC over 16 mo of aging was consistent. In bone
marrow cells at 2 mo of age, defective HSCs were unde-
tectable by limiting dilution analysis of unseparated bone
marrow cells, but they were detected at 3.7 cells per 105
bone marrow cells from 18-mo-old mice. According to
single cell reconstitution data, defective HSCs were present
at rates of ,0.5 CD342KSL cells per 105 bone marrow
cells at 2 mo of age. In 18-mo-old mice, defective HSCs
were estimated to be present at 2.9 CD342KSL cells per
105 bone marrow cells. Therefore, defective HSC increased
nearly sixfold in a population of CD342KSL cells.
An important question that should be addressed is how
HSCs become defective with time. It has been suggested
that the length of telomeres limits a life-span of normal so-
matic cells (20, 21), including HSCs (13). Correlation of
telomerase activity and self-renewal potential has been sug-
gested for hematopoietic cells (22). Telomere length can be
an indicator of replicative history for HSCs. However, ag-
ing in HSCs may be not related solely to shortening of
telomeres, since, as shown in this study, aging preferentially
affects the lymphoid differentiation potential of HSCs but
does not affect their myeloid differentiation potential nor
their self-renewal potential.
Apart from repopulating cells, the majority of expanded
CD342KSL cells were interpreted as members of a class of
myeloid progenitors with in vitro colony-forming ability
but without in vivo repopulating potential. However, it is
possible that these cells are repopulating cells with defective
homing ability, as previously suggested (6).
Consistent with a pervious report (6), the cell cycle status
of CD342KSL cells was shown to be steady from 2 to 18
mo of age. Fewer than 3% of these cells were in S/G2/M
phases of the cell cycle at any point in time. However, the
50% turnover time was estimated to be only 21 d when
2-mo-old mice were studied. Our data support the notion
that most HSCs continuously enter the cell cycle in a
shorter interval than has been previously considered (17,
23). However, it remains uncertain whether CD342KSL
cells from 18-mo-old mice show cell cycle kinetics like
those of young mice.
From the viewpoint of self-renewal, the properties de-
scribed above can be related. We propose an aging model
for HSCs. HSCs could have a certain likelihood of self-
renewal via symmetric division. Most of the time, HSCs in
cell cycle undergo asymmetric divisions, but sometimes
symmetric rather than asymmetric division takes place un-
der physiological conditions. Expanded HSCs may have
some sort of defect in maintenance of lymphoid lineage re-
populating potential and may give rise to defective HSCs,
which may finally commit to myeloid progenitor cells. As a
result, aged mice exhibit accumulations of HSCs, defective
HSCs, and myeloid progenitors, which together form a hi-
Figure 4. BrdU incorporation by CD342KSL cells. After administra-
tion of BrdU to mice, CD342KSL cells (d) and lineage marker–negative
cells (s) were isolated from the mice and analyzed for BrdU uptake (A).
The data are shown with a function of logarithmic percent of BrdU-neg-
ative cells (B).
Table VII. Frequencies of CD342KSL Cells among Bone 
Marrow Cells
Age of mice
Cells 2 mo 18 mo Fold increase
Total CD342KSL cells 5 87 17.4
HSCs 1.6 3.8 2.2
Defective HSCs ,0.5 2.9 .5.8
Progenitor cells 1.9 60.0 31.6
Unidentified cells 1.0 20.3 20.3
The number of cells per 105 bone marrow cells is shown. The fold
increase from 2 to 18 mo of age is also shown. The frequency of total
CD342KSL cells in bone marrow cells was obtained by FACS® analysis.
Frequencies of HSCs, defective HSCs, and progenitor cells among
CD342KSL cells were estimated using functional assays. Proceeding
from the assumption that all HSCs and defective HSCs have colony-
forming ability in vitro, the numbers of colony-forming cells without
repopulating activity were calculated; these cells were classified as
myeloid progenitors. Cells without colony-forming and repopulating
ability are shown as unidentified cells.1280 Age-associated Characteristics of Murine Hematopoietic Stem Cells
erarchy in a primitive hematopoietic compartment. We
hope that further studies on the regulation of self-renewal
of HSCs will test this hypothesis.
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